Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single drug therapy for intractable epilepsy.

D Schmidt

    Journal of Neurology
    |January 1, 1983
    PubMed
    Summary

    Optimal single drug therapy with phenytoin or primidone effectively controlled seizures in 31% of patients with complex-partial epilepsy. Achieving therapeutic drug levels and ensuring patient compliance are crucial for managing intractable epilepsy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.

    The American journal of pathology·1995
    Same author

    [Placental site trophoblastic tumor. Morphology, differential diagnosis and prognosis].

    Der Pathologe·1995
    Same author

    Retinal vascular hamartoma in von Hippel-Lindau disease.

    Archives of ophthalmology (Chicago, Ill. : 1960)·1995
    Same author

    Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1995
    Same author

    The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions.

    Pathology, research and practice·1995
    Same author

    [Fatigue fractures of the sacrum in primary biliary liver cirrhosis].

    Aktuelle Radiologie·1995

    Area of Science:

    • Neurology
    • Clinical Pharmacology

    Background:

    • Intractable epilepsy with complex-partial seizures presents significant treatment challenges.
    • Optimizing monotherapy is a key strategy in epilepsy management.

    Purpose of the Study:

    • To evaluate the efficacy of single-drug therapy with phenytoin or primidone in patients with uncontrolled chronic epilepsy.
    • To investigate the relationship between plasma drug concentrations, patient compliance, and seizure control.

    Main Methods:

    • Retrospective analysis of 35 patients with complex-partial seizures treated with either phenytoin or primidone monotherapy.
    • Measurement of plasma concentrations of phenytoin and phenobarbitone.
    • Assessment of patient compliance.

    Main Results:

    • Complete seizure control was achieved in 11 of 35 patients (31%).
    • Seizure control correlated with increased plasma concentrations of phenytoin and phenobarbitone.
    • Low initial plasma concentrations (<11 µg/ml) were observed in 40% of patients.
    • Non-compliance was reported by 23% of patients.

    Conclusions:

    • Single-drug therapy with phenytoin or primidone can be effective in a subset of patients with intractable complex-partial epilepsy.
    • Therapeutic plasma drug concentrations and patient compliance are critical factors for successful monotherapy.
    • Optimizing monotherapy represents a clinically valuable approach for managing difficult-to-treat epilepsy.

    Related Experiment Videos